pirfenidone has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Jong, PA; De Raedt, N; Dupont, LJ; Gheysens, O; Ruttens, D; Van Raemdonck, DE; Vanaudenaerde, BM; Vandermeulen, E; Verleden, GM; Verleden, SE; Vos, R; Yserbyt, J | 1 |
| Bondue, B; Castiaux, A; Doumont, G; Egrise, D; Goldman, S; Huaux, F; Lacroix, S; Mathey, C; Sherer, F; Van Simaeys, G | 1 |
2 other study(ies) available for pirfenidone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Pirfenidone: a potential new therapy for restrictive allograft syndrome?
Topics: Allografts; Anti-Inflammatory Agents, Non-Steroidal; Emphysema; Fluorodeoxyglucose F18; Humans; Lung Transplantation; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Pulmonary Fibrosis; Pyridones; Radiopharmaceuticals; Syndrome; Tumor Necrosis Factor-alpha | 2013 |
Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
Topics: Aged; Animals; Antineoplastic Agents; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Male; Mice; Mice, Inbred C57BL; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Pyridones | 2019 |